Asimov Stock
Asimov develops software for mammalian cell engineering to accelerate the design and manufacture of biologics and gene therapies. The company’s platform combines synthetic biology, biophysical simulations, and machine learning to engineer genetic circuits, enabling optimized genetic logic gates and advanced therapeutic applications.
Founded: 2017
For more Asimov stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Douglas Densmore Co-founder |
| Ben Gordon Chief Innovation Officer |
| Raja Srinivas Co-founder |
| Christopher Voigt Co-founder |
| Alec Nielsen Co-Founder and CEO |
